1. Home
  2. NTIC vs INKT Comparison

NTIC vs INKT Comparison

Compare NTIC & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation

HOLD

Current Price

$8.00

Market Cap

83.1M

Sector

Industrials

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$11.66

Market Cap

70.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTIC
INKT
Founded
1970
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.1M
70.6M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
NTIC
INKT
Price
$8.00
$11.66
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
12.2K
46.5K
Earning Date
04-09-2026
05-15-2026
Dividend Yield
0.49%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$84,234,474.00
N/A
Revenue This Year
$12.49
N/A
Revenue Next Year
$7.64
N/A
P/E Ratio
$402.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.10
$6.66
52 Week High
$10.03
$76.00

Technical Indicators

Market Signals
Indicator
NTIC
INKT
Relative Strength Index (RSI) 41.98 50.64
Support Level $7.91 $10.88
Resistance Level $8.25 $12.58
Average True Range (ATR) 0.18 1.06
MACD 0.01 -0.10
Stochastic Oscillator 16.67 26.18

Price Performance

Historical Comparison
NTIC
INKT

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Share on Social Networks: